Pharmaceutical
Learn about the latest developments in the pharmaceutical cannabis industry with Business of Cannabis. Discover new drugs, research, and more.
Pharmaceutical · page 11
- Cultivation
Cannabis investing versus sports betting right now
CANN OR BET? The pros and cons of cannabis investing vs. sports betting Since regulators aren’t overly keen on legalizing either, which is the better buy: sports betting or cannabis MSOs, asks Baystreet.
- Pharmaceutical
Summerway Capital Returns To AIM To Fund £80m Take-Over Of UK Cannabis Cultivator
SUMMERWAY Capital’s (LON: SWC) £80m reverse takeover of one of the UK’s few licenced high-THC cannabis growers has seen it relaunch its shares on the London Stock Exchange (LSE) in order to fund its new acquisition.
- Pharmaceutical
OCT Board ‘Not At All Concerned’ About Losing Jobs as Co-Founder Calls for Sweeping Removals
Oxford Cannabinoid Technologies (OCT) published its interim results this week reporting ‘good progress’ on all of its key development programmes, but its stock price was dragged down once again following fresh controversy among its board members.
- Hemp Industry
Is the market clamoring for odorless cannabis?
ODOURLESS Does anyone want odourless cannabis? The lab results are in on Brampton-based CannabCo Pharmaceutical Corp.’s proprietary cannabis strain, The Odourless Cannabis™, which—you guessed it—was designed to not have the distinct flavours and aromas usually associated with quality bud.
- Pharmaceutical
EU Cannabis Stocks Review: OCT’s Co-Founder Demands Removal Of All 6 Directors – More from Akanda, MGC Pharmaceuticals & Apollon
We start this week’s EU Cannabis Stocks Review with some breaking news from Oxford Cannabinoid Technologies, after the company’s co-founder calls for a general meeting in an attempt enact a dramatic management overhaul.
- Hemp Industry
As Gordon Ramsay says, “Shut it down!” in New York
CLOSE…OR ELSE New York’s unlicensed dispensaries warned to close Cannabis shops suspected of participating in “illegal gifting” of THC products pre-legalized sales in New York have received cease-and-desist letters from the State’s Office of Cannabis Management, reports Cannabis Business Times.
- Pharmaceutical
EU Cannabis Stocks Review: Love Hemp jumps 60%, OCT sees recovery & more from Cellular Goods, Chill Brands and MGC Pharma
On the 1-year anniversary of the first cannabis company to list on the London Stock Exchange, we examine the reaction to a number of significant announcements from some of the UK’s biggest cannabis players, making for an eventful week in the markets.
- CBD Market
Supporting women to be empowered through cannabis
After an MS diagnosis, Jasmin Thomas is helping women to be empowered economically and in their health through CBD and cannabis.
- Cultivation
New report says Canadian cannabis market contributed $43.5 billion to GDP
It reported that $25.2 billion of that contribution comes from labour income and it has helped to create 151,000 jobs
- Pharmaceutical
Who is right about Canadian cannabis job numbers?
HOW MANY CANADIAN JOBS AGAIN? Does Deloitte’s latest report inflate cannabis job numbers?
- Pharmaceutical
Oxford Cannabinoid Technologies sees changes across the board
Richard Guy Hathaway has been appointed as non-executive director, and Julie Pomeroy has been appointed non-executive chair.
- Pharmaceutical
Oxford Cannabinoid Technologies Welcomes Imperial Brands Director to Board and Appoints New Chair
Richard Guy Hathaway has been appointed to the Board as a Non-Executive Director, as a representative of Imperial Brands Ventures Limited (“Imperial”), with effect from 1 February 2022.
